openheart.bmj14h
Stroke and bleeding risks in Asian and non-Asian patients with atrial fibrillation: further insights into the ‘East Asian Paradox’
The ‘East Asian Paradox’ refers to a unique risk-benefit trade-off observed in Asian patients for thrombosis versus bleeding, ...
openheart.bmj1d
Peripandemic outcomes of infants treated for sentinel congenital heart diseases in England and Wales
Background Infants with congenital heart disease (CHD) are clinically vulnerable to cardiac deteriorations and intercurrent ...
openheart.bmj1d
Mechanical circulatory support in cardiogenic shock: translating trial evidence into real-world practice
While iterative developments have improved outcomes of patients with myocardial infarction, mortality in patients with acute ...
openheart.bmj5d
APCU 16 A retrospective study of permanent pacemaker implantation in a university hospital
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...
openheart.bmj6d
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel
Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of cardiovascular diseases. However, clopidogrel responsiveness shows ...